Drug Profile
Cell culture derived influenza vaccine - AbbVie
Alternative Names: Influvac TC; Influvac TC (cell-based seasonal vaccine); Influvac® TC EU; Influvac® TC USLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Solvay Pharmaceuticals
- Developer Abbott Healthcare Products; Abbott Laboratories
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Influenza virus infections